EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

MYC and AP-1 oncogenes cooperatively bind enhancers to rewire transcription

Reshma Kalyan Sundaram iD, Kshitiz Parihar iD, Stephanie Monson iD, Ravi Radhakrishnan iD, Bomyi Lim iD

NAR Cancer · 08.04.2026 · 8 (2)

DOI: 10.1093/narcan/zcag010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NAR Cancer, online erschienen am 08.04.2026. Verfasst von Reshma Kalyan Sundaram und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering, University of Pennsylvania, Philadelphia, PA, 19104, United States. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-myc, Enhancer Elements, Genetic, Transcription Factor AP-1, Transcription, Genetic. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The transcription factor c-MYC (MYC) is deregulated in ~70% of human cancers. Through de novo motif discovery analysis on published MYC ChIP-seq datasets from cancer cell lines, we found cell-type-specific co-enrichment of the TRE motifs (AP-1 binding sites) alongside MYC’s canonical EBOX motif. MYC binds indirectly to TRE motifs in cooperation with AP-1 transcription factors, and these indirect interactions occur predominantly at enhancers rather than promoters. At elevated MYC levels, as seen in cancers, MYC’s indirect binding to TRE sites at enhancers increases. Integration of ChIP-seq and RNA sequencing data revealed that TRE enhancer-binding sites are frequently associated with MYC-mediated transcriptional repression. Gene Ontology analysis showed that MYC utilizes TRE sites to transcriptionally rewire cells, modulating cancer hallmarks like proliferation, apoptosis, and cell adhesion. These molecular insights into how increased MYC levels alter gene regulation could inform new therapeutic strategies targeting cancer-specific MYC functions and its co-regulators.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-mycEnhancer Elements, GeneticTranscription Factor AP-1Transcription, GeneticNeoplasmsHumansGene Expression Regulation, NeoplasticBinding SitesCell Line, TumorOncogenesProtein BindingPromoter Regions, Genetic

Substanzen

Proto-Oncogene Proteins c-mycTranscription Factor AP-1MYC protein, human

Autor:innen und Institutionen

  • Department of Chemical and Biomolecular Engineering, University of Pennsylvania, Philadelphia, PA, 19104, United States.
  • Department of Bioengineering,University of Pennsylvania, Philadelphia, PA, 19104, United States.

ORCID-Profile: Reshma Kalyan Sundaram, Kshitiz Parihar, Stephanie Monson, Ravi Radhakrishnan, Bomyi Lim

Förderung

  • NCI NIH HHS
  • NIH HHS
  • National Institutes of Health
  • Center for Precision Engineering for Health

Zitieren

APA

Kalyan Sundaram, R., Parihar, K., Monson, S., Radhakrishnan, R., & Lim, B. (2026). MYC and AP-1 oncogenes cooperatively bind enhancers to rewire transcription. NAR Cancer, 8(2). https://doi.org/10.1093/narcan/zcag010

Vancouver

Kalyan Sundaram R, Parihar K, Monson S, Radhakrishnan R, Lim B. MYC and AP-1 oncogenes cooperatively bind enhancers to rewire transcription. NAR Cancer. 2026;8(2). doi:10.1093/narcan/zcag010

BibTeX
@article{KalyanSundaram2026,
  author = {Kalyan Sundaram, Reshma and Parihar, Kshitiz and Monson, Stephanie and Radhakrishnan, Ravi and Lim, Bomyi},
  title = {MYC and AP-1 oncogenes cooperatively bind enhancers to rewire transcription},
  journal = {NAR Cancer},
  year = {2026},
  volume = {8},
  number = {2},
  doi = {10.1093/narcan/zcag010}
}
Kostenlos starten →